Dashboard
Manage Tickers

SGHT Sight Sciences, Inc.

Nasdaq sightsciences.com


$ 3.46 $ -0.12 (-3.35 %)    

Thursday, 16-Oct-2025 11:08:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.84 $ -0.37 (-0.06 %)
DIA $ 462.73 $ -0.73 (-0.16 %)
SPY $ 665.71 $ -1.18 (-0.18 %)
TLT $ 90.78 $ 0.28 (0.31 %)
GLD $ 393.00 $ 1.85 (0.47 %)
$ 3.6
$ 3.58
$ 3.44 x 100
$ 3.53 x 100
$ 3.46 - $ 3.46
$ 2.03 - $ 6.08
86,150
na
188.52M
$ 1.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-07-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-06-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-08-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-neutral-on-sight-sciences-lowers-price-target-to-4
Citigroup Maintains Neutral on Sight Scien...
10/07/2025 17:48:36

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and lowers the price target from $4.5...

sight-sciences-highlights-meta-analysis-of-2379-eyes-showing-omni-delivers-sustained-iop-reductions-and-medication-free-outcomes
Sight Sciences Highlights Meta-Analysis Of...
09/17/2025 11:11:50

unitedhealthcare-adds-sight-sciences-omni-system-to-covered-glaucoma-surgery-procedures
UnitedHealthcare Adds Sight Sciences OMNI ...
09/09/2025 15:39:52

UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate o...

sight-sciences-omni-surgical-system-to-be-included-in-unitedhealthcares-expanded-coverage-of-glaucoma-surgical-treatments
Sight Sciences' OMNI Surgical System To Be...
09/09/2025 11:07:22

sight-sciences-publishes-dry-eye-workshop-iii-report-from-tear-film-and-ocular-surface-society-in-american-journal-of-ophthalmology
Sight Sciences Publishes Dry Eye Workshop ...
09/02/2025 20:07:12

needham-reiterates-hold-on-sight-sciencesto-hold
Needham Reiterates Hold on Sight Sciencest...
08/28/2025 16:44:29

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) from Hold to Hold.

what-4-analyst-ratings-have-to-say-about-sight-sciences
What 4 Analyst Ratings Have To Say About S...
08/21/2025 19:00:41

citigroup-maintains-neutral-on-sight-sciences-raises-price-target-to-45
Citigroup Maintains Neutral on Sight Scien...
08/21/2025 18:14:30

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.6...

lake-street-upgrades-sight-sciences-to-buy-raises-price-target-to-5
Lake Street Upgrades Sight Sciences to Buy...
08/08/2025 22:18:39

Lake Street analyst Frank Takkinen upgrades Sight Sciences (NASDAQ:SGHT) from Hold to Buy and raises the price target from $...

sight-sciences-raises-fy2025-sales-guidance-from-70000m-75000m-to-72000m-76000m-vs-72431m-est
Sight Sciences Raises FY2025 Sales Guidanc...
08/07/2025 20:16:39

Sight Sciences (NASDAQ:SGHT) raises FY2025 sales outlook from $70.000 million-$75.000 million to $72.000 million-$76.000 millio...

sight-sciences-q2-eps-023-beats-029-estimate-sales-19564m-beat-18183m-estimate
Sight Sciences Q2 EPS $(0.23) Beats $(0.29...
08/07/2025 20:09:02

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

sight-sciences-study-finds-tearcare-more-effective-and-cheaper-than-cyclosporine-for-dry-eye-relief
Sight Sciences Study Finds TearCare More E...
07/30/2025 11:13:01

Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and com...

sight-sciences-unveils-24-month-sahara-rct-results-showing-durable-repeatable-relief-from-dry-eye-with-just-12-tearcare-treatments-per-year
Sight Sciences Unveils 24-Month SAHARA RCT...
07/29/2025 11:11:00

the-analyst-verdict-sight-sciences-in-the-eyes-of-4-experts
The Analyst Verdict: Sight Sciences In The...
07/15/2025 19:00:50

morgan-stanley-maintains-equal-weight-on-sight-sciences-raises-price-target-to-4
Morgan Stanley Maintains Equal-Weight on S...
07/15/2025 13:13:01

Morgan Stanley analyst Cecilia Furlong maintains Sight Sciences (NASDAQ:SGHT) with a Equal-Weight and raises the price targe...

piper-sandler-maintains-neutral-on-sight-sciences-raises-price-target-to-4
Piper Sandler Maintains Neutral on Sight S...
06/18/2025 15:21:48

Piper Sandler analyst Adam Maeder maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3....

citigroup-maintains-neutral-on-sight-sciences-raises-price-target-to-36
Citigroup Maintains Neutral on Sight Scien...
05/22/2025 17:38:38

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.2...

lake-street-maintains-hold-on-sight-sciences-raises-price-target-to-3
Lake Street Maintains Hold on Sight Scienc...
05/09/2025 14:49:27

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:SGHT) with a Hold and raises the price target from $2.5 ...

sight-sciences-affirms-fy2025-sales-guidance-of-7000m-7500m-vs-7213m-est
Sight Sciences Affirms FY2025 Sales Guidan...
05/08/2025 20:47:00

Sight Sciences (NASDAQ:SGHT) affirms FY2025 sales outlook from $70.00 million-$75.00 million to $70.00 million-$75.00 million v...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION